Drug Research

Abzena, the leading end-to-end CDMO for biologics and bioconjugates, has launched AbZelect™ and AbZelectPRO™ cell line development (CLD) platforms for accelerating the generation of production cell lines for manufacture of antibodies and recombinant proteins. The platforms will enable Abzena...

A novel benchmark study in the UK has gone on to show that blending whole-genome sequencing- WGS and real-world clinical data at a national scale can go on to help deliver customized cancer therapy. The study, which got published in...

Apparently, when a grocery store goes on to steeply discount rotting cuts of meat or produce, would one buy them? May be not. If we go by the same logic, if a pharmacy went ahead and sold medications that...

Antimicrobial Resistance- AMR as it is referred to, is rising, and an AMR review that was commissioned by the UK Government has gone on to predict that by 2050, an additional 10 million people may as well succumb to...

The pharmaceutical sector has gone on to face pressure as well as uncertainty in 2023, and that is in all likelihood going to continue in 2024, partially due to the execution as well as evolution of the Inflation Reduction...

A paper that has been published in the European Journal of Pharmaceutics and Biopharmaceutics has gone on to review the present application status of Quality by Design- QbD within the framework of the ICH guidelines- ICH Q8(R2) – Q14...

The Worldwide Advanced Empty Capsule sector is anticipated to be worth US$ 905.6 million this year in 2023 and is expected to key in a CAGR of 7.4% in the next 10 years. It is well to be noted...